ZAMEROVIMAB
UNII DX0L1Z7JO9

Substance Identification & Data

This profile provides standardized clinical and technical data for Zamerovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DX0L1Z7JO9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2419087-87-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DX0L1Z7JO9

CAS Registry Number

2419087-87-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZAMEROVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C184875

National Cancer Institute reference terminology for clinical and research data.

INN ID

11747

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zamerovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZAMEROVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(RABIES LYSSAVIRUS SPIKE GLYCOPROTEIN G) (HUMAN-MUS MUSCULUS CLONE 1A9 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE 1A9 .KAPPA.-CHAIN, DIMER

ZAMEROVIMAB [INN]